Moderna is a biotechnology company that researches & markets mRNA therapeutics for genetic disorders, oncology treatments & a COVID-19 vaccine.Read more
Moderna's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 15.8B. Over the last four quarters, Moderna's revenue has grown by 2657.3%. Specifically, in Q2 2021's revenue was $4.4B; in Q1 2021, it was $1.9B; in Q4 2020, it was $570.5M; in Q3 2020, Moderna's revenue was $157.9M.